EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

When culture-based whole-genome sequencing can change management in severe ocular bacterial infections

Inès Fenniri iD, Camille André iD

mBio · 13.05.2026 · 17 (5)

DOI: 10.1128/mbio.00659-26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift mBio, erschienen am 13.05.2026. Verfasst von Inès Fenniri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Eye Infections, Bacterial, Bacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nationwide multicenter surveillance demonstrates a substantial burden of antimicrobial resistance among ocular bacterial pathogens. In the 2009–2018 ARMOR collection, methicillin-resistant Staphylococcus aureus (MRSA) accounted for 34.9% of S. aureus ocular isolates, and methicillin resistance was strongly associated with fluoroquinolone resistance. Ocular infections can destroy tissue within hours; timely microbiologic diagnosis and treatment adjustment are essential; however, culture is constrained by small specimen volumes, low inoculum, and prior antimicrobial exposure. To tackle multidrug-resistant (MDR) infections, we propose that phenotypic testing could be complemented with targeted whole-genome sequencing in cases of severe or persistent eye infections, to provide lineage characterization, resistance and virulence determinants, and critical features of pathogenic MDR bacteria that are clinically relevant to predict patient outcomes. A genome-informed workflow, sequencing from pure culture, and integration with phenotypic data could refine empiric therapy, enable earlier de-escalation, and strengthen surveillance of high-risk lineages to reduce vision-threatening treatment failures and save patients’ vision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole Genome SequencingEye Infections, BacterialBacteriaHumansAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialGenome, BacterialMethicillin-Resistant Staphylococcus aureus

Stichwörter der Autor:innen

antimicrobial resistancediagnosticseye infectionsgenomics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Hospices Civils de Lyon, Lyon, France.
  • Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
  • Infectious Disease Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Inès Fenniri, Camille André

Zitieren

APA

Fenniri, I., & André, C. (2026). When culture-based whole-genome sequencing can change management in severe ocular bacterial infections. mBio, 17(5). https://doi.org/10.1128/mbio.00659-26

Vancouver

Fenniri I, André C. When culture-based whole-genome sequencing can change management in severe ocular bacterial infections. mBio. 2026;17(5). doi:10.1128/mbio.00659-26

BibTeX
@article{Fenniri2026,
  author = {Fenniri, Inès and André, Camille},
  title = {When culture-based whole-genome sequencing can change management in severe ocular bacterial infections},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {5},
  doi = {10.1128/mbio.00659-26}
}
Kostenlos starten →